piperazine has been researched along with Depression in 5 studies
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression is the single largest contributor to global disability with a huge economic and social burden on the world." | 2.72 | Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships. ( Akhtar, MJ; Kumar, B; Kumar, RR; Pathania, S; Sahu, B; Singh, PK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shang, Y | 1 |
| Wang, M | 1 |
| Hao, Q | 1 |
| Meng, T | 1 |
| Li, L | 1 |
| Shi, J | 1 |
| Yang, G | 1 |
| Zhang, Z | 1 |
| Yang, K | 1 |
| Wang, J | 1 |
| Huang, Z | 1 |
| Yin, L | 1 |
| Guan, L | 1 |
| Li, Z | 1 |
| Tan, C | 1 |
| Kumar, RR | 1 |
| Sahu, B | 1 |
| Pathania, S | 1 |
| Singh, PK | 1 |
| Akhtar, MJ | 1 |
| Kumar, B | 1 |
| Gupta, S | 1 |
| Pandey, D | 1 |
| Mandalapu, D | 1 |
| Sharma, V | 1 |
| Shukla, M | 1 |
| Singh, S | 2 |
| Singh, N | 1 |
| Yadav, SK | 1 |
| Tanpula, DK | 1 |
| Maikhuri, JP | 1 |
| Shukla, S | 1 |
| Lal, J | 1 |
| Siddiqi, MI | 1 |
| Gupta, G | 1 |
| Sharma, VL | 1 |
| Demir Özkay, Ü | 1 |
| Yurttaş, L | 1 |
| Özkay, Y | 1 |
| Üçel, UI | 1 |
| Can, ÖD | 1 |
| Öztürk, Y | 1 |
1 review available for piperazine and Depression
| Article | Year |
|---|---|
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships.
Topics: Antidepressive Agents; Depression; Drug Development; Humans; Molecular Structure; Piperazine; Struct | 2021 |
4 other studies available for piperazine and Depression
| Article | Year |
|---|---|
Development of indole-2-carbonyl piperazine urea derivatives as selective FAAH inhibitors for efficient treatment of depression and pain.
Topics: Amidohydrolases; Animals; Depression; Endocannabinoids; Enzyme Inhibitors; Heterocyclic Compounds; H | 2022 |
Novel piperazine-2,5-dione analogs bearing 1H-indole: Synthesis and biological effects.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antidepressive Agents; Depression; Drug Discovery; In | 2020 |
Novel aryl piperazines for alleviation of 'andropause' associated prostatic disorders and depression.
Topics: Androgen Antagonists; Andropause; Animals; Cell Line; Depression; Down-Regulation; Humans; Male; Mol | 2017 |
Synthesis of new 1-phenyl-2-(4-substituted-piperazin-1-yl)-propanol derivatives and evaluation of their antidepressant-like effects.
Topics: Animals; Antidepressive Agents; Depression; Drug Evaluation, Preclinical; Hindlimb Suspension; Mice; | 2013 |